dc.contributor.author |
Chiva-Blanch, Gemma |
dc.contributor.author |
Suades Soler, Rosa, 1984- |
dc.contributor.author |
Crespo, Javier |
dc.contributor.author |
Vilahur, Gemma |
dc.contributor.author |
Arderiu, Gemma |
dc.contributor.author |
Padró, Teresa |
dc.contributor.author |
Corella, Dolores |
dc.contributor.author |
Salas-Salvadó, Jordi |
dc.contributor.author |
Arós, Fernando |
dc.contributor.author |
Martínez-González, Miguel Ángel, 1957- |
dc.contributor.author |
Ros, Emilio |
dc.contributor.author |
Fitó Colomer, Montserrat |
dc.contributor.author |
Estruch, Ramón |
dc.contributor.author |
Badimón, Lina, 1953- |
dc.date.accessioned |
2016-07-19T09:47:33Z |
dc.date.issued |
2016 |
dc.identifier.citation |
Chiva-Blanch G, Suades R, Crespo J, Vilahur G, Arderiu G, Padró T. et al. CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event. Int J Cardiol. 2016 Apr 1;208:147-9. doi: 10.1016/j.ijcard.2016.01.211 |
dc.identifier.issn |
0167-5273 |
dc.identifier.uri |
http://hdl.handle.net/10230/27086 |
dc.description.abstract |
Circulating microparticles (cMPs) are phospholipid-rich blebs of 0.1–1.0 μm in size shed from the plasma membrane of eukaryotic cells when injured, activated, or undergoing apoptosis. MPs have been shown to reflect cellular activation and/or tissue degeneration occurring in vivo. |
dc.description.sponsorship |
GC-B is a Sara Borrell Postdoctoral Fellow (CD13/00023) from Instituto de Salud Carlos III. This work has been possible thanks to funding received from Spanish Ministry of Economy and Competitiveness (Plan Estatal de I + D + I 2013–2016, SAF2013-42962-R, to LB), from the Cardiovascular Research Network of Instituto de Salud Carlos III (RIC, RD12/0042/0027 to LB; SAF2012-40208 to GV) and from CIBER CB06/03 Fisiopatología de la Obesidad y la Nutrición of Instituto de Salud Carlos III, (CIBERobn, RD06/0045 to RE). JS-S and RE thank the Fundació la Marató TV3. CIBEROBN is an initiative of ISCIII, Spain. |
dc.format.mimetype |
application/pdf |
dc.language.iso |
cat |
dc.publisher |
Elsevier |
dc.relation.ispartof |
International Journal of Cardiology. 2016 Apr 1;208:147-9 |
dc.rights |
© Elsevier. http://dx.doi.org/10.1016/j.ijcard.2016.01.211 |
dc.subject.other |
Sistema cardiovascular -- Malalties |
dc.subject.other |
Limfòcits |
dc.title |
CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event. |
dc.type |
info:eu-repo/semantics/article |
dc.identifier.doi |
http://dx.doi.org/10.1016/j.ijcard.2016.01.211 |
dc.rights.accessRights |
info:eu-repo/semantics/openAccess |
dc.type.version |
info:eu-repo/semantics/acceptedVersion |